Introduction
The role of nutrition in Peripheral Arterial Disease (PAD) is recognised in the management of risk factors of PAD development and progression with specific dietary and nutrient clinical experience in the area of medical nutrition therapy for patients with PAD and whether the participant routinely treated patients with PAD with those answering 'no' directed to the end of the questionnaire and thanked for their participation. The remainder of the questionnaire comprised of 15 items designed to gain an insight into the dietetic practice of estimating energy and protein requirements for each clinical stage of PAD as defined by Rutherford and colleagues, [14] outlined in Table 1 .
On receipt of the completed questionnaires the predictive equations for estimating energy and protein requirements that were most commonly reported by participants were applied to a 'typical patient' to gain an insight into the range and potential overlap of estimations by stage of PAD. Data for the typical asymptomatic PAD patient (ICD I70.20, n=622), claudicant (ICD I70.21, n=384), patient with ischemic rest pain (ICD I70.22, n=86) and tissue loss (ICD I70.23, n=234) were obtained from the 45 and Up Study, the largest ongoing study of healthy ageing in the Southern Hemisphere and coordinated by the Sax Institute, New South Wales Australia [15] . The 'typical patient' for each stage of PAD based on the 45 and Up Study data was then used in all estimations of requirements in this study. Based on the information obtained regarding methods for energy and protein estimation, the authors developed a set of definitions based on evidence-based guidlines [16] for parameters used in estimation of energy and protein requirements. These are outlined in Table  2 .
All de-identified data were imported from Survey Monkey into SPSS, version 19.0 (SPSS Inc, Chicago, IL, USA). Responses were displayed through the use of descriptive statistics to highlight trends. Continuous data were presented either as mean with 95% confidence intervals or median with Inter Quartile Range (IQR) depending on the distribution of the data. All categorical data were displayed as frequency and percentages of participants with each response.
Results
Of 4918 eligible persons, 45 dietitians responded to the online questionnaire. Of these, 23 (51%) did not routinely see PAD patients within their dietetic practice and therefore were not permitted to complete caseload and practice-based questions, providing a final sample size of 22 for the purpose of subsequent analyses. The methods of estimating energy and protein requirements used by participants according to each stage of PAD are shown in Table 3 and Table 4 respectively. The reasons provided for the selection of particular methods of estimating energy and protein requirements varied and included: training, clinical experience and evidence. Individual participants did not report altering the method used for estimation of energy requirements according to stage of PAD, however 10 (46%) participants reported that they would alter the method used for estimating protein requirements according to stage of PAD with requirements increasing as PAD progressed. Tables 3 and  4 illustrate that application of the methods used by participants for estimating energy and protein requirements resulted in very little variation across the stages of PAD. The only variation occurred if a dietitian were to apply an adjustment factor to account for sepsis, in patients with rest pain or tissue loss, when estimating protein requirements. In contrast, within each stage of PAD, participants did report a variety of methods for calculating estimated energy and protein requirements resulting in a range of estimated energy requirements that varied by more than 5000kJ/day and a variation of up to 55g/day for protein requirements within each PAD stage.
Discussion
This small cross-sectional study found that in the absence of specific, evidence-based recommendations, respondents used a variety of methods when estimating either dietary energy or protein requirements for patients with PAD and the variability in estimates when applied to a typical patient, would be of sufficient magnitude to have a clinically meaningful impact on patient outcomes. Furthermore, this study found that adjustment for stage of PAD when estimating dietary energy requirements was uncommon.
The findings of the present study would indicate that evidence-based recommendations to guide dietitians when estimating the energy and protein requirements of patients with PAD would be worthwhile to improve consistency in approach. The study showed that dietitians in Australia recognise that there are additional dietary energy needs during times of wound healing however when these adjustments were applied to a typical patient it resulted in only 1,000kJ extra. It might be argued that dietitians would review this estimation by monitoring body weight over time, and in the case of chronic arterial ulcers, this would be considered a valid argument. It is not however a valid argument to suggest that there are no differences in dietary energy requirements between the other three stages of PAD [17, 18] and that monitoring would allow for adjustments as asymptomatic patients and those with claudication or rest pain would rarely be seen regularly enough to detect clinically meaningful changes in body weight. The magnitude of the variability in estimates observed in this study could translate to a concerning potential weight gain or loss of more than 1kg/week in males and 0.5-1kg/ week in females.
Unlike estimates of energy requirements, some dietitians in this study did report that they were likely to adjust dietary protein requirements with stage of PAD. Despite this, when the adjustment factors reported were applied to the typical patient, the dietary protein requirements for those with sepsis, rest pain or tissue loss were similar to estimates for asymptomatic PAD patients and those with claudication. Conventional management of these patients is supervised exercise training and emerging evidence suggests that repeated exposure to ischemic reperfusion injury initiates muscle atrophy, specifically in the symptomatic leg [19] . Accurate dietary protein estimates and prescription is likely critical in the prevention of this adverse outcome.
It is important to declare that this study is not devoid of limitations and hence interpretation of the findings should be considered with caution. The small sample of dietitians (n=22) who responded to the questionnaire is one important limitation that may impact on the generalisability of the findings. The widely accepted Dillman Protocol for Web-Based Surveys [13] was used with the intention to maximise response rates through the use of reminder emails and simple questionnaire design. The sample included dietitians Australia-wide and it is interesting to note that their characteristics were not dissimilar to those of the DAA member population according to the 2011 DAA Annual Report [20] . Some of the assumptions made in the calculations of requirements for the typical patients may not be truly reflective of the intentions of those completing the questionnaire. We multiplied BMR by an activity factor of 1.2 across all stages of PAD for our estimations of energy requirements however it could be argued that a higher activity factor would be more applicable for asymptomatic patients. Notwithstanding the validity of this argument, the net result of a higher activity factor would be minimal (~500kJ for an increase to 1.3) and it would not affect our findings relating to the large variation in estimating requirements of both energy and protein within each stage of PAD.
The accurate determination of dietary energy and protein requirements for PAD patients should be a priority area of research. The rate of growth in the aging population of western countries, in conjunction with a rise in Type 2 diabetes mellitus and overweight/obesity will see the number of PAD patients increase within the next decade and beyond. There was significant variation in energy and protein estimates within this study which is possibly due to the little evidence available to inform dietitians on how to best treat this patient group. Therefore, the creation of new evidence from well designed studies with larger sample sizes investigating the energy and protein requirements, and the development and communication of evidence-based guidelines on how to adequately provide nutritional care to PAD patients is an urgent area for further research. In the interim, dietitians should use available equations for estimating requirements with caution and closely monitor the nutritional intake and nutritional status of this patient group allowing adjustment of estimates over time.
